D-Kimia
View this profile on Briter Intelligence platform
Type
startup
Founded
2013
Funding captured
undisclosed
Deals captured
0
About D-Kimia
D-Kimia develops novel and affordable diagnostic solutions to detect a broad range of diseases, initially focusing on the identification of the hepatitis C virus (HCV) that affects over 170 million people worldwide.